Inactive
U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Dual Study Program in Business Administration Intern - Digital Business Management

Higher Education FacultyPosted on Sep 7
Internship · Summer 2027

About the Job

Requirements

  • Applicants must have a general higher education entrance qualification (Abitur) or a university of applied sciences entrance qualification (Fachhochschulreife).
  • Applicants must have good to very good mathematics skills.
  • Applicants must have good to very good written and spoken English.
  • Applicants must have basic knowledge of Microsoft Office, particularly Excel, Word, and PowerPoint.
  • Applicants should be able to work independently and have some initial professional experience, for example through internships or part-time jobs.
  • Applicants should be actively involved in school or extracurricular activities.
  • Applicants must have German language skills, as most communication and teaching throughout the program will be in German.
  • Applicants who are not German citizens or do not hold permanent residency must have a valid residence and work permit at the time of application.
  • Candidates must have, or be able to independently obtain in due time, the required authorization to study, reside, and work in Germany for the Dual Study Program; UCB does not provide visa sponsorship.

Responsibilities

  • Complete a two-month onboarding period at UCB in Monheim am Rhein before academic studies begin.
  • Alternate every three months between academic phases at DHBW in Mannheim and practical placements at UCB in Monheim am Rhein.
  • Complete tailored practical placements and gain insight into business functions including Human Resources, Finance, Marketing and Corporate Communications, Digitalisation and Operational Excellence, Market Access, Drug Safety, and Medical and Quality.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs